PQ 664
664. Deputy Jennifer Murnane O'Connor asked the Minister for Health the considerations his Department is giving to the inclusion of the drugs saxenda and ozempic, both now recognised as valuable medications in the treatment of obesity, to the drugs payment scheme for non-diabetic patients; if there are plans to widen the prescription of saxenda and ozempic to medical card holders with a BMI of greater than 35 as a preventative medicine; and if he will make a statement on the matter. [25689/23]
Introduced
30 May 2023
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
30 May 2023
Summary
664. Deputy Jennifer Murnane O'Connor asked the Minister for Health the considerations his Department is giving to the inclusion of the drugs saxenda and ozempic, both now recognised as valuable medications in the treatment of obesity, to the drugs payment scheme for non-diabetic patients; if there are plans to widen the prescription of saxenda and ozempic to medical card holders with a BMI of greater than 35 as a preventative medicine; and if he will make a statement on the matter. [25689/23]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 30 May 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2023-05-30/664/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2023-05-30/pq_664